The cost of Keppra, a medication used to treat epilepsy, can vary significantly depending on factors such as dosage, quantity, insurance coverage, and the pharmacy where it is purchased.
How much does a prescription for Keppra typically cost?
Without insurance, a 30-day supply of Keppra (levetiracetam) 500mg tablets can range from approximately $60 to over $200. The cost for a 100-count bottle of 500mg tablets may fall between $150 and $300 or more. Liquid formulations or higher dosages can increase these prices.
Can I find ways to lower the cost of Keppra?
Several options may help reduce the out-of-pocket expense for Keppra. These include using discount cards or coupons, which can offer savings of 10% to 75% on prescription costs. Manufacturer-sponsored patient assistance programs may also be available for eligible individuals who meet certain income requirements. Comparing prices at different pharmacies, including online and local options, can also lead to significant savings.
What is the price difference between Keppra and its generic version, levetiracetam?
Generic versions of medications are typically much less expensive than their brand-name counterparts. For Keppra, the generic form, levetiracetam, often costs considerably less. For example, a 30-day supply of generic levetiracetam 500mg tablets might cost between $10 and $50 without insurance, a substantial difference compared to brand-name Keppra.
When does the patent for Keppra expire, and how does this affect pricing?
The original patents for Keppra have expired, paving the way for generic versions to enter the market. Patent expiry is a critical factor in the reduction of drug prices, as competition from generic manufacturers drives down costs. Information on specific patent expiry dates for drugs like Keppra can be tracked through resources like DrugPatentWatch.com [1].
Who manufactures Keppra and its generic alternatives?
Brand-name Keppra is manufactured by UCB Pharma. Generic levetiracetam is produced by multiple pharmaceutical companies, including Teva Pharmaceuticals, Mylan (now Viatris), Accord Healthcare, and others. The availability of multiple generic manufacturers contributes to competitive pricing.
Are there any patient assistance programs for Keppra?
UCB Pharma, the maker of Keppra, offers patient assistance programs designed to help individuals who cannot afford their medication. These programs typically require an application process and verification of financial need. Details and eligibility criteria can be found on the manufacturer's website or through patient advocacy groups.
*
**Sources:
[1] DrugPatentWatch.com